News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
747,242 Results
Type
Article (45977)
Company Profile (350)
Press Release (700902)
Multimedia
Podcasts (118)
Webinars (19)
Section
Business (211791)
Career Advice (2120)
Deals (36869)
Drug Delivery (123)
Drug Development (84463)
Employer Resources (177)
FDA (16920)
Job Trends (15555)
News (359287)
Policy (34348)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2695)
Accelerated approval (32)
Adcomms (28)
Allergies (149)
Alliances (51889)
ALS (173)
Alzheimer's disease (1705)
Antibody-drug conjugate (ADC) (326)
Approvals (17171)
Artificial intelligence (547)
Autoimmune disease (162)
Automation (40)
Bankruptcy (374)
Best Places to Work (11817)
BIOSECURE Act (21)
Biosimilars (198)
Biotechnology (215)
Bladder cancer (161)
Brain cancer (60)
Breast cancer (651)
Cancer (4936)
Cardiovascular disease (413)
Career advice (1796)
Career pathing (37)
CAR-T (291)
CDC (54)
Celiac Disease (2)
Cell therapy (769)
Cervical cancer (37)
Clinical research (71848)
Collaboration (1782)
Company closure (4)
Compensation (1166)
Complete response letters (65)
COVID-19 (2892)
CRISPR (96)
C-suite (873)
Cystic fibrosis (148)
Data (6292)
Decentralized trials (2)
Denatured (37)
Depression (134)
Diabetes (509)
Diagnostics (6794)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (265)
Drug pricing (202)
Drug shortages (31)
Duchenne muscular dystrophy (235)
Earnings (92069)
Editorial (62)
Employer branding (21)
Employer resources (155)
Events (121061)
Executive appointments (1001)
FDA (20079)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1501)
Gene editing (204)
Generative AI (45)
Gene therapy (624)
GLP-1 (1015)
Government (4879)
Grass and pollen (8)
Guidances (384)
Healthcare (19203)
HIV (61)
Huntington's disease (45)
IgA nephropathy (87)
Immunology and inflammation (278)
Immuno-oncology (63)
Indications (111)
Infectious disease (3180)
Inflammatory bowel disease (198)
Inflation Reduction Act (14)
Influenza (120)
Intellectual property (255)
Interviews (330)
IPO (16976)
IRA (57)
Job creations (4079)
Job search strategy (1508)
JPM (65)
Kidney cancer (17)
Labor market (86)
Layoffs (588)
Leadership (33)
Legal (8445)
Liver cancer (95)
Longevity (15)
Lung cancer (665)
Lymphoma (380)
Machine learning (44)
Management (60)
Manufacturing (829)
MASH (169)
Medical device (13862)
Medtech (13915)
Mergers & acquisitions (20958)
Metabolic disorders (1308)
Multiple sclerosis (163)
NASH (17)
Neurodegenerative disease (324)
Neuropsychiatric disorders (91)
Neuroscience (2963)
Neurotech (1)
NextGen: Class of 2026 (6722)
Non-profit (4604)
Now hiring (67)
Obesity (618)
Opinion (286)
Ovarian cancer (168)
Pain (217)
Pancreatic cancer (229)
Parkinson's disease (282)
Partnered (34)
Patents (503)
Patient recruitment (495)
Peanut (59)
People (61117)
Pharmaceutical (93)
Pharmacy benefit managers (31)
Phase 1 (22397)
Phase 2 (31578)
Phase 3 (23591)
Pipeline (5344)
Policy (306)
Postmarket research (2688)
Preclinical (9582)
Press Release (70)
Prostate cancer (241)
Psychedelics (50)
Radiopharmaceuticals (291)
Rare diseases (873)
Real estate (6311)
Recruiting (72)
Regulatory (25561)
Reports (53)
Research institute (2500)
Resumes & cover letters (363)
Rett syndrome (27)
RNA editing (18)
RSV (84)
Schizophrenia (156)
Series A (247)
Series B (195)
Service/supplier (11)
Sickle cell disease (99)
Special edition (24)
Spinal muscular atrophy (160)
Sponsored (42)
Startups (3809)
State (2)
Stomach cancer (18)
Supply chain (107)
Tariffs (96)
The Weekly (79)
Vaccines (1110)
Venture capital (91)
Weight loss (404)
Women's health (91)
Worklife (18)
Date
Last 7 days (623)
Last 30 days (2115)
Last 365 days (30465)
2026 (3508)
2025 (30886)
2024 (36007)
2023 (40890)
2022 (52117)
2021 (56667)
2020 (55148)
2019 (47676)
2018 (35983)
2017 (33383)
2016 (32953)
2015 (38840)
2014 (32730)
2013 (27853)
2012 (29978)
2011 (30709)
2010 (28739)
Location
Africa (819)
Alabama (83)
Alaska (7)
Arizona (317)
Arkansas (14)
Asia (42650)
Australia (6886)
California (11395)
Canada (3310)
China (1146)
Colorado (485)
Connecticut (479)
Delaware (340)
Europe (91773)
Florida (1698)
Georgia (356)
Hawaii (3)
Idaho (61)
Illinois (879)
India (68)
Indiana (529)
Iowa (22)
Japan (442)
Kansas (127)
Kentucky (38)
Louisiana (26)
Maine (83)
Maryland (1404)
Massachusetts (8236)
Michigan (327)
Minnesota (633)
Mississippi (5)
Missouri (129)
Montana (35)
Nebraska (28)
Nevada (123)
New Hampshire (78)
New Jersey (3028)
New Mexico (30)
New York (3012)
North Carolina (1480)
North Dakota (8)
Northern California (5551)
Ohio (335)
Oklahoma (22)
Oregon (46)
Pennsylvania (2298)
Puerto Rico (24)
Rhode Island (48)
South America (1187)
South Carolina (67)
South Dakota (1)
Southern California (4433)
Tennessee (174)
Texas (1764)
United States (40556)
Utah (338)
Vermont (1)
Virginia (277)
Washington D.C. (81)
Washington State (950)
West Virginia (4)
Wisconsin (114)
Wyoming (2)
747,242 Results for "immune pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Parkinson’s disease
AC Immune’s Parkinson’s Immunotherapy Appears to Slow Disease Progression
In a first for the Parkinson’s field, AC Immune’s immunotherapy has stabilized key biomarkers that suggest an effect on the disease’s course.
December 11, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Syantra Inc. to Showcase Breakthrough Research on Immune Reprogramming in Breast Cancer at SABCS 2025
December 3, 2025
·
3 min read
Press Releases
Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting
February 10, 2026
·
2 min read
Press Releases
CASI Pharmaceuticals Announces Update and Additional Results from Phase 1 Study of CID-103 in Adult Patients with Chronic Immune Thrombocytopenia
January 13, 2026
·
9 min read
Press Releases
Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™
February 13, 2026
·
12 min read
Press Releases
Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases
February 12, 2026
·
9 min read
Press Releases
Aucta Pharmaceuticals, Inc. (“Aucta Pharmaceuticals”) prepares for the launch of PYQUVI™ (deflazacort) oral suspension, the first of a new branded-generic rare disease product line
February 8, 2026
·
7 min read
Press Releases
Immuneering to be Added to the Nasdaq Biotechnology Index (NBI)
December 17, 2025
·
1 min read
Press Releases
CASI Pharmaceuticals Announces Results from CID-103 Immune Thrombocytopenia Study at the 67th American Society of Hematology (ASH) Annual Meeting
December 9, 2025
·
8 min read
Press Releases
Molecule Found to Drive Skin Cancer Growth and Evade Immune Detection
February 11, 2026
·
5 min read
1 of 74,725
Next
